Inside Precision Medicine October 29, 2025
Jonathan D. Grinstein, PhD

The T.Rx Capital co-founder discusses techbio, biotech, and AI financing trends, and international markets and politics as investing risk factors

Jonathan D. Grinstein, PhD, North American Editor of Inside Precision Medicine, hosts a new series called Behind the Breakthroughs that features the people shaping the future of medicine. With each episode, Jonathan gives listeners access to his guests’ motivational tales and visions for this emerging, game-changing field.

If you work in biotech, the name Langer likely rings a bell. Robert Langer—the MIT legend behind Moderna, more than forty biotech startups, and some of the most cited papers in science—has become almost synonymous with innovation itself. His lab, one of the largest and most prolific in the world, consistently drives more...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article